Search Results - "Díaz Morfa, M."

Basal 18F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment by Jiménez Londoño, G.A., García Vicente, A.M., Poblete García, V.M., Amo-Salas, M., Calle Primo, C., Ibañez García, Á., Martínez Sanchís, B., López-Fidalgo, J.F., Solano Ramos, F., Martínez Hellín, A., Díaz Morfa, M., Soriano Castrejón, Á.

“…To analyze the relationship of clinical variables related to prognosis and tumor burden, with metabolic variables obtained in the staging 18F-FDG PET/CT, and…”
Get full text

Basal 18F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment by Jiménez Londoño, G.A., García Vicente, A.M., Poblete García, V.M., Amo-Salas, M., Calle Primo, C., Ibañez García, Á., Martínez Sanchís, B., López-Fidalgo, J.F., Solano Ramos, F., Martínez Hellín, A., Díaz Morfa, M., Soriano Castrejón, Á.

“…To analyze the relationship of clinical variables related to prognosis and tumor burden, with metabolic variables obtained in the staging 18F-FDG PET/CT, and…”
Get full text

Basal 18 F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment by Jiménez Londoño, G.A., García Vicente, A.M., Poblete García, V.M., Amo-Salas, M., Calle Primo, C., Ibañez García, Á., Martínez Sanchís, B., López-Fidalgo, J.F., Solano Ramos, F., Martínez Hellín, A., Díaz Morfa, M., Soriano Castrejón, Á.

Get full text

Basal18 F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment by Jiménez Londoño, G.A, García Vicente, A.M, Poblete García, V.M, Amo-Salas, M, Calle Primo, C, Ibañez García, Á, Martínez Sanchís, B, López-Fidalgo, J.F, Solano Ramos, F, Martínez Hellín, A, Díaz Morfa, M, Soriano Castrejón, Á

“…Abstract Aim To analyze the relationship of clinical variables related to prognosis and tumor burden, with metabolic variables obtained in the staging18 F-FDG…”
Get full text

136 Using flow cytometry for differential diagnosis of thrombocytopenia by Subira, D, de Miguel, D, Román, I. San, Morfa, M. Díaz, Golbano, N, Morales, D, Arbeteta, J, Herrero, S, Fuertes, F, Pinedo, B

Get full text

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens by Sobas, Marta, Montesinos, Pau, Boluda, Blanca, Bernal, Teresa, Vellenga, Edo, Nomdedeu, Josep, González-Campos, Jose, Chillón, Maria, Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, González-Sanmiguel, José David, Gil-Cortes, Cristina, Tormo, Mar, Salamero, Olga, Manso, Felix, Fernández, Isolda, de la Serna, Javier, Moreno, María-José, Pérez-Encinas, Manuel, Krsnik, Isabel, Ribera, Josep-Maria, Escoda, Lourdes, Lowenberg, Bob, Sanz, Miguel Angel

“…Out of 956, there were 95 (10%) CD56+ APL patients treated with PETHEMA ATRA and chemotherapy. CD56+ expression was associated with high WBC, BCR3 isoform, and…”
Get full text

Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment by Jiménez Londoño, G A, García Vicente, A M, Poblete García, V M, Amo-Salas, M, Calle Primo, C, Ibañez García, Á, Martínez Sanchís, B, López-Fidalgo, J F, Solano Ramos, F, Martínez Hellín, A, Díaz Morfa, M, Soriano Castrejón, Á

“…To analyze the relationship of clinical variables related to prognosis and tumor burden, with metabolic variables obtained in the staging (18)F-FDG PET/CT, and…”
Get more information

Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols by del Potro, E, Díaz Mediavilla, J, Martínez, R, Alvarez, A, Krsnik, I, Guerra, J L, Llorente, L, López, J C, Díaz Morfa, M, Villegas, A

“…We report our eight year experience remission induction therapy in adult patients with acute myeloblastic leukemia. Overall 67 patients were treated, with a…”
Get more information

Complete remission without marrow aplasia phase in a patient with acute promyelocytic leukosis treated with aggressive chemotherapy by del Potro Gómez, E, Martínez Martínez, R, López Martín, J C, Díaz Morfa, M, Díaz Mediavilla, J, Espinos Pérez, D

“…A patient diagnose of acute promyelocytic leukemia treated with chemotherapy schedule type VAPA. 2 weeks after the administration, there was no response this…”
Get more information

Megaloblastic anemia caused by a congenital deficiency of transcobalamin II by Villegas, A, Arrabal, M C, López Rubio, M, Díaz Morfa, M

Get more information

Free erythrocytic protoporphyrin and thalassemic trait by López Rubio, M, López Quintela, P, Díaz Morfa, M, Navarro, F, Villegas, A

Get more information